Targeting of liposomes within cardiovascular system

Journal of Liposome Research

Volumn 7, Issue 4, 1997, Pages 433-454

  Torchilin, Vladimir P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOLIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; MYOSIN ANTIBODY;

CARDIOVASCULAR SYSTEM; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; HEART INFARCTION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031470695     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109709035511     Document Type: Review

References (43)

1. Poste, G. and Kirsh, R. 1983. Site-specific (targeted) drug delivery in cancer therapy. Biotechnology 1:869-878.
2. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature 362:801-809.
3. Chazov, E.I., Alexeev, A.V., Antonov, A.S., Koteliansky, V.E., Leytin, V.L., Ljubimova, E.V., Repin, V.S., Sviridov, D.D., Torchilin, V.P. and Smimov, V.N. 1981. Endothelial cell culture on fibrillar collagen: Model to study platelet adhesion and liposome targeting to intercellular collagen matrix. Proc. Natl. Acad. Sci. U.S.A. 78:5603-5607.
4. Torchilin,V.P., Klibanov, A.L., Ivanov, N.N., Glukhova, M.A., Koteliansky, V.E., Kleinman, H.K. and Martin, O.P. 1985. Binding of antibodies in liposomes to extracellular matrix antigens. J. Cell. Bioch. 28:23-29.
5. Torchilin.V.P., Omelyanenko, V.G., Klibanov, A.L., Mikhailov, A.I., Goldansky, V.I. and Smirnov, V.N. 1980. Incorporation of hydrophilic protein modified with hydrophobic agent into liposome membrane. Biochim. Biophys. Acta 602:511-521.
6. Smirnov, V.N., Domogatsky, S.P., Dolgov, V.V., Hvatov, V.B., Klibanov, A.L., Koteliansky, V.E., Muzykantov, V.R., Repin, V.S., Samokhin, O.P., Shekhonin, B.V., Smimov, M.D., Sviridov, D.D., Torchilin, V.P. and Chazov, E.I. 1986. Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc. Natl. Acad. Sci. U.S.A. 83:6603-6607.
7. Trubetskaya, O.V., Trubetskoy, V.S., Domogatsky, S.P., Rudin, A.V., Popov, N.V., Danilov, S.M., Klibanov, A.L. and Torchilin, V.P. 1988. Monoclonal antibody to human endothelial cell surface: internalization and liposome delivery in cell culture. FEBS Lett. 228:131-134.
8. Caride, V.J. and Zaret, B.L. 1977. Liposome accumulation in regions of experimental myocardial infarction. Science 198:735-738.
9. Kayawake, S. and Kako, K.J. 1982. Association of liposomes with the isolated perfused rabbit heart. Basic Res. Cardiol. 77:668-681.
10. Mueller, T.M., Marcus, M.L., Mayer, H.E., Williams, J:K. and Hermsmeyer, K. 1981. Liposome concentration in canine ischemie myocardium and depolarized myocardial cells. Circ. Res. 49:405-415.
11. Cole, A.W., Kingaby, R.O., Lab, MJ. and Palmer, T.N. 1982. Myocardial liposome uptake in the early stages of myocardial infarction. Cardiovasc. Res. 16:516-523.
12. Caride, V.J., Twickler, J. and Zaret, B.L. 1984. Liposome kinetics in infarcted canine myocardium. J. Cardiovasc. Pharmacol. 6:996-1005.
13. Palmer, T.N., Caride, V.J., Fernandez, L.A. and Twickler, J. 1981. Liposome accumulation in ischaemic intestine following experimental mesenteric occlusion. Biosci. Rep. 1:337-344.
14. Palmer, T.N., Caride, V.J., Caldecourt, M.A., Twicjler, J. and Abdullah, V. 1984. The mechanism of liposome accumulation in infarction. Biochim. Biophys. Acta 797:363-368.
15. Palmer, T.N., Caldercourt, M.A. and Kingaby, R.O. 1984. Liposome drug delivery in chronic ischemia. Biochem. Soc. Trans. 12:344-345.
16. Baldeschweiler, J.D. 1990. Liposomal targeting of ischemie tissue. Intl. Patent 9012595.
17. Nguen, P.D., Orear, E.A., Johnson, A.E., Patterson, E., Whitsett, T.L. and Bhakta, R. 1990. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal incapsulation of streptokinase. Circ. Res. 66:875-878.
18. Tang, C.S., Su, J.Y., Li, Z.P. Zhang, L.Z., Yang, J., Qi, M., Liu, F.A. and Tang, J. 1993. Possibility of targeting treatment for ischémie heart disease with liposome (I). Sci. China. B. 36:590-598.
19. Tang, C.S., Su, J.Y., Li, Z.P. Zhang, L.Z., Yang, J., Qi, M., Liu, F.A. and Tang, J. 1993. Possibility of targeting treatment for ischémie heart disease with liposome (II). Sci. China. B. 36:809-816.
20. Jadot, G. and Michelson, A.M. 1987. Comparative anti-inflammatory activity of different Superoxide dismutases and liposomal SOD in ischemia. Free Radical Res. Commun. 3:389-394.
21. Phelan, A.M. and Lange, D.G. 1991. Ischemia-reperfiision-induced changes in membrane fluidity characteristics of brain capillary endothelial cells and its prevention by liposomal-incorporated Superoxide dismutase. Biochim. Biophys. Acta 1067:97-102.
22. Bkaily, G., Sperelakis, N., Elishalom, Y. and Barenholz, Y. 1983. Effect of Na+- or Ca2+-filled liposomes on electrical activity of cultured heart cells. Am. J. Physiol. 245 (Heart Circ. Physiol. 14):H756-H761.
23. Laham, A., Claperon, N., Durussel, J.J., Fattal, E., Delattre, J., Puisieux, F., Couvreur, P. and Rossignol, P. 1988. Liposomally entrapped adenosine triphosphate inproved efficiency against experimental brain ischaemia in the rat. J. Chromatogr. 440:455-458.
24. Khaw, B.A. 1994. Antimyosin antibody for the diagnosis of acute myocardial infarction: experimental validation. In: "Monoclonal Antibodies in Cardiovascular Diseases." B.A.Khaw, J.Narula and H.W.Strauss (Eds.). Lea and Febiger, Malvern, p. 15-29.
25. Khaw, B.A., Beller, G.A., Haber, E. and Smith, T.W. 1976. Localization of cardiac myosin-specific antibody in myocardial infarction. J. Clin. Invest. 58: 439-446.
26. Khaw, B.A., Fallon, J.T., Beller, G.A. and Haber, E. 1979. Specificity of localization of myosin specific antibody fragments in experimental myocardial infarction: histologie, histochemical, autoradiographic and scintigraphic studies. Circulation 60:1527-1531.
27. Khaw, B.A., Scott, J., Fallon, J.T., Haber, E. and Homey, C. 1982. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science 217:1050-1053.
28. Khaw, B.A., Beller, G.A. and Haber, E. 1978. Experimental myocardial infarct imaging following intravenous administration of iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin. Circulation 57:743-750.
29. Khaw, B.A., Mattis, J.A., Melincoff, G., Strauss, H.W., Gold, H.K. abd Haber, E. 1984. Monoclonal antibody to cardiac myosin: scintigraphic imaging of experimental myocardial infarction. Hybridoma 3:11-23.
30. Johnson, L.L., Seldin, D.W., Becker, L.C., LaFrance, N.D., Liberman, H.A., James, C., Mattis, J.A., Dean, R.T., Brown, J., Reiter, A., Arneson, V., Cannon, P.J. and Berger, HJ. 1989. Antimyosin imaging in acute transmural myocardial infarction: results of a multicenter clinical trial. J. Am. Coll. Cardiol. 13:27-35.
31. Torchilin, V.P., Khaw, B.A., Smimov, V.N. and Haber, E. 1979. Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem. Biophys. Res. Commun. 89:1114-1119.
32. Klibanov, A.L., Maruyama, K., Torchilin, V.P. and Huang, L. 1990. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235-237.
33. Torchilin, V.P., Klibanov, A.L., Huang, L., O'Donnell, S., Nossiff, N.D. and Khaw, B.A. 1992. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J. 6:2716-2719.
34. Weissig, V., Lasch, J., Klibanov, A.L. and Torchilin, V.P. 1986. A new hydrophobic anchor for the attachment of proteins to liposomal membranes. FEBS Lett. 202:86-90.
35. Torchilin, V.P., Narula, J., Halpem, E. and Khaw, B.A. 1996. Polyethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium. Biochim. Biophys. Acta 1279:75-83.
36. Torchilin, V.P., Narula, J. and Khaw, B.A. 1994. Delivery of pharmaceuticals by long-circulating immunoliposomes: factors influencing longevity and target accumulation. In: Proceedings of the 21st International Symposium on Controlled Release of Bioactive Materials, Nice, France. Controlled Release Society, p. 222-223.
37. Gabizon, A.A. 1995. Liposome circulation time and tumor targeting: implications for cancer chemotherapy. Adv. Drug Deliv. Rev. 16:285-294.
38. Gabizon, A.A. 1992. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 52:891-896.
39. Jennings, R.B., Schaper, J., Hill, M.L., Steenberg, C., Jr. and Reimer, K.A. 1985. Effect of reperfusion late in the phase of reversible ischemic injury: changes in cell volume, electrolytes, metabolites, and ultrastructure. Cire. Res. 56:262-278.
40. Reimer, K.A., Jennings, R.B. and Tatum, A.H. 1983. Pathobiology of acute myocardial ischemia: Metabolic, functional and ultrastructural studies. Am. J. Cardiol. 52:72A-82A.
41. Braunwald, E. and Kloner, R.A. 1985. Myocardial reperfusion: a double edged sword? J. Clin. Invest. 76:1713-1719.
42. Khaw, B.A., Torchilin, V.P., Vural, I. and Narula, J. 1995. Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nature Med. 1:1195-1198.
43. Khaw, B.A., Vural, I., Narula, J., Haider, N. and Torchilin, V.P. 1996. Preservation of cardiocyte viability by immunoliposome-cell membrane sealing at 1, 2, 3, 4 and 5 days of hypoxia. In: Proceedings of the 23d International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japan. Controlled Release Society, p. 617-618.